(Q34404612)

English

The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature

scientific article published on 13 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

object named as

Olivia Wu

3

0 references

Thomas W. Kelsey

object named as

Thomas W Kelsey

2

0 references

Scott M. Nelson

object named as

Scott M Nelson

5

0 references

author name string

Stamatina Iliodromiti

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Richard A Anderson

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

13 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Human Reproduction Update

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

560-570

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

A systematic review of tests predicting ovarian reserve and IVF outcome

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The diagnostic odds ratio: a single indicator of test performance

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Serum antimüllerian hormone is not predictive of oocyte quality in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

A unification of models for meta-analysis of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Serum anti-Mullerian hormone levels affect the rate of ongoing pregnancy after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Guidelines for meta-analyses evaluating diagnostic tests.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

External validation of anti-Müllerian hormone based prediction of live birth in assisted conception

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Systematic reviews to evaluate diagnostic tests

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The journey from the old to the new AMH assay: how to avoid getting lost in the values

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The ageing ovary and uterus: new biological insights

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Maternal age and fetal loss: population based register linkage study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The poor responder in IVF: is the prognosis always poor?: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Maternal antimullerian hormone levels do not predict fetal aneuploidy

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Human ovarian reserve from conception to the menopause

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU003

21 January 2018

Identifiers

10.1093/HUMUPD/DMU003

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

release_a5pcjuqywfc4vbogdw6jc5ukii

1 reference

https://api.fatcat.wiki/v0/release/a5pcjuqywfc4vbogdw6jc5ukii

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34404612&oldid=1836248070"